• Europe's biggest private biotech company raises $270 million biospectrumasia
    December 24, 2018
    Europe’s largest privately held biotech company, Germany-based BioNTech, has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.
PharmaSources Customer Service